Constraint-Induced Movement Therapy or CI Therapy is a form of treatment that systematically employs the application of selected behavioral techniques delivered in intensive treatment over consecutive day with the following strategies utilized: behavioral strategies are implemented to improve the use of the more- affected limb in life situation called a Transfer Package (TP), motor training using a technique called shaping to make progress in successive approximations, repetitive, task oriented training, and strategies to encourage or constrain participants to use the more-affected extremity including restraint of the less-affected arm in the upper extremity (UE) protocol. Numerous studies examining the application of CI therapy with UE rehabilitation after stroke have demonstrated strong evidence for improving the amount of use and the quality of the more-affected UE functional use in the participant's daily life situation. CI Therapy studies with adults, to date, have explored intensive treatment for participants with a range from mild-to-severe motor impairment following stroke with noted motor deficits and limited use of the more-affected arm and hand in everyday activities. Each CI Therapy protocol was designed for the level of impairment demonstrated by participants recruited for the study. However, often following stroke, patients not only have motor deficits but somatosensory impairments as well. The somatosensory issues have not, as yet, been systematically measured and trained in CI Therapy protocols with adults and represent an understudied area of stroke recovery. We hypothesize that participants with mild-to-severe motor impairment and UE functional use deficits can benefit from CI therapy protocols that include somatosensory measurement and training components substituted for portions of motor training without loss in outcome measure gains. Further, we hypothesize that adults can improve somatosensory outcomes as a result of a combined CI therapy plus somatosensory component protocol.
Age range
18 Years – 89 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Motor Activity Log
Timeframe: At post treatment after 2 weeks of intervention for participants with mild-moderate UE impairment
Motor Activity Log
Timeframe: At 3 month follow up after the end of treatment
G4/5 Motor Activity Log
Timeframe: At post treatment after 3 weeks of intervention for participants with severe UE impairment
G4/5 Motor Activity Log (G4/5 MAL)
Timeframe: At 3 month follow up after the end of treatment
Wolf Motor Function Test(WMFT)
Timeframe: At post treatment after the 2 weeks of intervention for mild to moderately impaired participants
Grade 5 Graded Wolf Motor Function Test (G5 GWMFT)
Timeframe: At post treatment after the 3 weeks of intervention for severely impaired participants
Canadian Occupational Performance Measure (COPM)
Timeframe: At post treatment after the 2-3 weeks of intervention, depending on the severity of the impairment.
Canadian Occupational Performance Measure (COPM)
Timeframe: At 3 month follow up after the end of treatment